24 related articles for article (PubMed ID: 12112411)
1. Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.
Paterson LM; Tyacke RJ; Nutt DJ; Knudsen GM
J Cereb Blood Flow Metab; 2010 Oct; 30(10):1682-706. PubMed ID: 20664611
[TBL] [Abstract][Full Text] [Related]
2. 5-tert-Butyl-2-(4'-[18F]fluoropropynylphenyl)-1,3-dithiane oxides: potential new GABA A receptor radioligands.
Li X; Jung YW; Snyder SE; Blair J; Sherman PS; Desmond T; Frey KA; Kilbourn MR
Nucl Med Biol; 2008 Jul; 35(5):549-59. PubMed ID: 18589299
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain.
Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K
Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of [11C]N-methylpyrrolidinyl benzilate ([11C]NMPYB) to endogenous acetylcholine: PET imaging vs tissue sampling methods.
Ma B; Sherman PS; Moskwa JE; Koeppe RA; Kilbourn MR
Nucl Med Biol; 2004 May; 31(4):393-7. PubMed ID: 15093808
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, (18)F-labeling, and biological evaluation of piperidyl and pyrrolidyl benzilates as in vivo ligands for muscarinic acetylcholine receptors.
Skaddan MB; Kilbourn MR; Snyder SE; Sherman PS; Desmond TJ; Frey KA
J Med Chem; 2000 Nov; 43(23):4552-62. PubMed ID: 11087580
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptors.
Skaddan MB; Kilbourn MR; Snyder SE; Sherman PS
J Cereb Blood Flow Metab; 2001 Feb; 21(2):144-8. PubMed ID: 11176279
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of novel PET ligands (+)N-[11C]methyl-3-piperidyl benzilate ([11C](+)3-MPB) and its stereoisomer [11C](-)3-MPB for muscarinic cholinergic receptors in the conscious monkey brain: a PET study in comparison with.
Tsukada H; Takahashi K; Miura S; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Hatazawa J; Okudera T
Synapse; 2001 Feb; 39(2):182-92. PubMed ID: 11180506
[TBL] [Abstract][Full Text] [Related]
8. (R)-N-[11C]methyl-3-pyrrolidyl benzilate, a high-affinity reversible radioligand for PET studies of the muscarinic acetylcholine receptor.
Skaddan MB; Jewett DM; Sherman PS; Kilbourn MR
Synapse; 2002 Jul; 45(1):31-7. PubMed ID: 12112411
[TBL] [Abstract][Full Text] [Related]
9. Using single photon emission tomography (SPECT) and positron emission tomography (PET) to trace the distribution of muscarinic acetylcholine receptor (MACHR) binding radioligands.
Kiesewetter DO; Carson RE; Jagoda EM; Herscovitch P; Eckelman WC
Life Sci; 1999; 64(6-7):511-8. PubMed ID: 10069517
[TBL] [Abstract][Full Text] [Related]
10. [Muscarinic cholinergic receptor imaging of parkinsonian brain using 11C-NMPB and PET].
Asahina M; Shinotoh H
Nihon Rinsho; 1997 Jan; 55(1):233-7. PubMed ID: 9014456
[TBL] [Abstract][Full Text] [Related]
11. Imaging of muscarinic receptors in the central nervous system.
Eckelman WC
Curr Pharm Des; 2006; 12(30):3901-13. PubMed ID: 17073686
[TBL] [Abstract][Full Text] [Related]
12. Update on PET Tracer Development for Muscarinic Acetylcholine Receptors.
Ozenil M; Aronow J; Millard M; Langer T; Wadsak W; Hacker M; Pichler V
Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34199622
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
